Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch, Study Says

The drug, omalizumab, known by its brand name, Xolair, is a monoclonal antibody approved to treat allergic asthma. In the Phase 3 trial, published online on Sunday in The New England Journal of Medicine, a monthly injection of the drug significantly reduced hives and itchiness - Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch ... - nytimes